The FDA approved the surgical robot in October 2019, and Hackensack purchased it shortly after in January. The robot features a 3D presurgical planning workstation and computer-assisted tool to help execute the procedure.
Yair David Kissin, MD, performed the procedure. He is one of the surgeons who participated in the platform’s investigational clinical trial.
More articles on robotics:
3 things to know about orthopedic surgeon salary & 4 other must-read articles
US ASC market to hit $84.1B by 2027
The No. 1 opportunity for ASC growth: 3 insights from Dr. Philip Schneider
